Kim Lorence H. 4/A
4/A · Revolution Medicines, Inc. · Filed Jun 28, 2024
Insider Transaction Report
Form 4/AAmended
Kim Lorence H.
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-20+15,955→ 15,955 totalExercise: $37.54Exp: 2034-06-19→ Common Stock (15,955 underlying) - Award
Common Stock
2024-06-20+4,248→ 69,948 total
Footnotes (2)
- [F1]Includes 8,623 restricted stock units ("RSUs").
- [F2]Shares subject to the Stock Option shall vest in full on the earlier of (i) the first anniversary of June 20, 2024 or (ii) immediately prior to the Issuer's annual meeting of stockholders following the date of grant, subject to the Reporting Person continuing in service through the vesting date.